The interference of cold ischemia time in the quality of total RNA from frozen tumor samples

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP VIANA, Cristiano Ribeiro
KERR, Ligia Maria
PALMERO, Edenir Inez
MARQUES, Marcia Maria Chiquitelli
QUEIROZ JUNIOR, Abel Feliciano de
CARVALHO, Andre Lopes
SIQUEIRA, Sheila Aparecida Coelho FMUSP-HC 2013
dc.identifier.citation CELL AND TISSUE BANKING, v.14, n.2, p.167-173, 2013
dc.identifier.issn 1389-9333
dc.description.abstract Tumor Banks were created to organize the collection, storage and distribution of biological samples from oncological patients, facilitating its use in cancer research. To ensure the quality of the samples from our bank, we implemented standard operating procedures international. In order to evaluate the influence of cold ischemia time (time between surgical removal of the specimen and the snap freezing of the sample) on the quality of the samples (evaluated by measurement integrity of their RNA), collected during 10 months two tumor samples from each donor, one with up to 30 min of cold ischemia and other with exact 45 min, totaling 100 different donors and 200 samples, 40 from each of the following organs: breast, thyroid, stomach, lung and colorectum. We extracted total RNA from the samples and with the aid of a Bioanalyser, evaluate their quality, comparing it with cold ischemia times in different organs. Among the samples up to 30 min and the samples with exact 45 min, we respectively found 63 (64.3 %) and 36 (36 %) with intact RNA, 11 (11.2 %) and 17 (17 %) partially degraded and 24 (24.5 %) and 47 (47 %) degraded (p < 0.001). Thyroid and colorectal samples were more sensitive to variations in cold ischemia time (p = 0.006 and p = 0.03, respectively). Stomach and lungs were less sensitive (p = 0.919 and p = 0.384, respectively). We concluded that the cold ischemia time up to 30 min was more efficient to maintain the integrity of RNA in most samples, and that RNA degradation varied according to the different topographies.
dc.description.sponsorship · Institute of Education and Research
dc.language.iso eng
dc.publisher SPRINGER
dc.relation.ispartof Cell and Tissue Banking
dc.rights restrictedAccess
dc.subject Tumor bank; RNA; Quality control; Degradation; Cold ischemia
dc.subject.other network; collection; banks
dc.title The interference of cold ischemia time in the quality of total RNA from frozen tumor samples
dc.type article
dc.rights.holder Copyright SPRINGER LIM/14
dc.identifier.doi 10.1007/s10561-012-9313-5
dc.identifier.pmid 22562477
dc.type.category original article
dc.type.version publishedVersion SIQUEIRA, Sheila Aparecida Coelho:HC:ICHC · VIANA, Cristiano Ribeiro:Barretos Canc Hosp, Pio Fdn 12, Dept Pathol, Barretos, Brazil
· SCAPULATEMPO NETO, Cristovam:Barretos Canc Hosp, Pio Fdn 12, Dept Pathol, Barretos, Brazil
· KERR, Ligia Maria:Barretos Canc Hosp, Pio Fdn 12, Dept Pathol, Barretos, Brazil
· PALMERO, Edenir Inez:Barretos Canc Hosp, Pio Fdn 12, Dept Mol Oncol, Barretos, Brazil
· MARQUES, Marcia Maria Chiquitelli:Barretos Canc Hosp, Pio Fdn 12, Dept Mol Oncol, Barretos, Brazil
· COLAIACOVO, Tamara:Barretos Canc Hosp, Pio Fdn 12, Bank Tumors, Barretos, Brazil
· QUEIROZ JUNIOR, Abel Feliciano de:Barretos Canc Hosp, Pio Fdn 12, Bank Tumors, Barretos, Brazil
· CARVALHO, Andre Lopes:Barretos Canc Hosp, Pio Fdn 12, Inst Educ & Res, Barretos, Brazil WOS:000319425200003 2-s2.0-84878734869 DORDRECHT NETHERLANDS
hcfmusp.relation.reference · Boudou-Rouquette P, 2010, VIRCHOWS ARCH, V456, P443, DOI 10.1007/s00428-010-0889-5
· Canadian Institutes of Health Research, 2010, MOD TUM BANK PROGR C
· Carvalho Lina, 2007, Acta Med Port, V20, P325
· CLAUSEN KP, 1989, CANCER, V63, P1452, DOI 10.1002/1097-0142(19890401)63:7<1452::AID-CNCR2820630736>3.0.CO;2-#
· Gene quantification, 2010, RNA INT QUANT
· Hatzis C, 2011, J NATL CANCER I, V103, P1871, DOI 10.1093/jnci/djr438
· Herpel E, 2010, VIRCHOWS ARCH, V457, P741, DOI 10.1007/s00428-010-0998-1
· Instituto Nacional do Cancer, 2010, INC CANC BRAS
· Isabelle M, 2006, EUR J CANCER, V42, P3103, DOI 10.1016/j.ejca.2006.04.032
· Lopez-Guerrero JA, 2006, EUR J CANCER, V42, P2924, DOI 10.1016/j.ejca.2006.04.030
· Mager SR, 2007, EUR J CANCER, V43, P828, DOI 10.1016/j.ejca.2007.01.002
· Morente MM, 2006, EUR J CANCER, V42, P2684, DOI 10.1016/j.ejca.2006.04.029
· Ooslerhuis JW, 2003, NAT REV CANCER, V3, P73
· Pitt KE, 2008, CELL PRESERV TECHNOL, DOI [10.1089/cpt.2008.9997, DOI 10.1089/CPT.2008.9997]
· Reis ST, 2010, INT BRAZ J UROL, V36, P348, DOI 10.1590/S1677-55382010000300012
· Riegman PH, 2008, MOL ONCOL, DOI [10.1016/j.molonc.2008.07.004, DOI 10.1016/J.M0L0NC.2008.07.004]
· Riegman PHJ, 2006, EUR J CANCER, V42, P2678, DOI 10.1016/j.ejca.2006.04.031
· Roa I, 2008, REV MED CHILE, V136, P733
· Rudloff U, 2010, ANN SURG ONCOL, V17, P2229, DOI 10.1245/s10434-010-0959-6
· Spruessel A, 2004, BIOTECHNIQUES, V36, P1030
· Tang W, 2012, J MOL DIAGN, DOI [10.1016/j.jmoldx.2011.09.003, DOI 10.1016/J.JM0LDX.2011.09.003]
· Thomas G, 2011, CELL TISSUE BANK, V12, P29, DOI 10.1007/s10561-010-9212-6
· van Veen EB, 2006, EUR J CANCER, V42, P2914, DOI 10.1016/j.ejca.2006.04.028
· Yu YY, 2010, WORLD GASTROINTEST O, DOI [10.4251/, DOI 10.4251/WJG0.V2.I1]
dc.description.index MEDLINE
hcfmusp.citation.scopus 20
hcfmusp.citation.wos 18 Brasil

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account